Strategic partnerships Leverage recent RDx asset acquisition from Vyaire Medical and distribution agreement with Medikro to expand OEM collaborations and broaden respiratory device portfolio in Europe and beyond.

Global expansion opportunities Target Nordic and European markets where distribution deals are in place or imminent, leveraging Trudell’s drug-free Aerobika OPEP and portable solutions to address rising respiratory care demand.

Channel and OEM sales Position as a white-label or co-branded device manufacturer for pharmaceutical and healthcare customers seeking high-quality aerosol drug delivery and lung health devices, expanding beyond branded sales.

Technology and integration Highlight compatibility with common tech ecosystems and e-commerce platforms to streamline partner onboarding and parts/device customization for pharmaceutical clients.

Growth through hiring Capitalize on headcount expansion history to reassure partners of scaling manufacturing capacity and on-time delivery capabilities for increasing orders and new product lines.